title: pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation.
abstract: In patients with von Hippel-Lindau (VHL) disease, renal cysts and clear cell renal cell carcinoma (ccRCC) arise from renal tubular epithelial cells containing biallelic inactivation of the VHL tumour suppressor gene. However, it is presumed that formation of renal cysts and their conversion to ccRCC involve additional genetic changes at other loci. Here, we show that cystic lesions in the kidneys of patients with VHL disease also demonstrate activation of the phosphatidylinositol-3-kinase (PI3K) pathway. Strikingly, combined conditional inactivation of Vhlh and the Pten tumour suppressor gene, which normally antagonises PI3K signalling, in the mouse kidney, elicits cyst formation after short latency, whereas inactivation of either tumour suppressor gene alone failed to produce such a phenotype. Interestingly, cells lining these cysts frequently lack a primary cilium, a microtubule-based cellular antenna important for suppression of uncontrolled kidney epithelial cell proliferation and cyst formation. Our results support a model in which the PTEN tumour suppressor protein cooperates with pVHL to suppress cyst development in the kidney.
authors.affiliation: Institute of Cell Biology, ETH Zurich, Zurich, Switzerland.
authors.forename: Ian J
authors.initials: IJ
authors.lastname: Frew
authors.forename: Claudio R
authors.initials: CR
authors.lastname: Thoma
authors.forename: Strahil
authors.initials: S
authors.lastname: Georgiev
authors.forename: Andrea
authors.initials: A
authors.lastname: Minola
authors.forename: Manuela
authors.initials: M
authors.lastname: Hitz
authors.forename: Matteo
authors.initials: M
authors.lastname: Montani
authors.forename: Holger
authors.initials: H
authors.lastname: Moch
authors.forename: Wilhelm
authors.initials: W
authors.lastname: Krek
mesh_terms: D000818:Animals; D049109:Cell Proliferation; D002923:Cilia / Q000201:enzymology / Q000473:pathology; D003560:Cysts / Q000201:enzymology* / Q000473:pathology*; D004789:Enzyme Activation; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D000071679:Glycogen Synthase Kinase 3 beta; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism; D052177:Kidney Diseases, Cystic / Q000201:enzymology* / Q000473:pathology*; D007686:Kidney Tubules, Distal / Q000201:enzymology / Q000473:pathology; D020935:MAP Kinase Signaling System; D051379:Mice; D009154:Mutation / Q000235:genetics; D051059:PTEN Phosphohydrolase / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000378:metabolism*
chemical_list: D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D019869:Phosphatidylinositol 3-Kinases; D000071679:Glycogen Synthase Kinase 3 beta; D051057:Proto-Oncogene Proteins c-akt; D048049:Extracellular Signal-Regulated MAP Kinases; D038362:Glycogen Synthase Kinase 3; D051059:PTEN Phosphohydrolase; C487757:Pten protein, mouse